Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (ChiCTR2500115256) titled 'Optimization Study on Community Screening Strategies for Prostate Cancer in Elderly Men with Serum PSA Levels of 2-4 ng/ml' on Dec. 24, 2025.
Study Type: Diagnostic test
Study Design:
Diagnostic test for accuracy
Primary Sponsor: Beijing Hospital
Condition:
Prostate cancer
Intervention:
Gold Standard:Pathological Results of Prostate Biopsy
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2025-12-25
Target Sample Size: Target condition:966;Difficult condition:15134
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=301673
Publis...